BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671 AND Prognosis
150 results:

  • 1. The role of insulinoma-associated protein 1 in predicting the progression and prognosis of human olfactory neuroblastoma in China.
    Yang Y; Yue C; Li Y; Piao Y
    Pathol Res Pract; 2024 Jan; 253():155040. PubMed ID: 38171083
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Increased plasma miR-370-3p expression in poor-outcome patients with pancreatic ductal adenocarcinoma.
    Harada T; Uemura K; Sumiyoshi T; Shintakuya R; Okada K; Hara T; Takahashi S; Hiyama E
    Pancreatology; 2023 Dec; 23(8):996-1002. PubMed ID: 37945497
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Reconsidering the absence of extrapancreatic extension in T staging for pancreatic adenocarcinoma in the AJCC (8
    Lee M; Thomas AS; Lee SY; Cho YJ; Jung HS; Yun WG; Han Y; Jang JY; Kluger MD; Kwon W
    J Gastrointest Surg; 2023 Nov; 27(11):2484-2492. PubMed ID: 37848688
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Impact of Preoperative Tumor Size on prognosis of Resectable and Borderline Resectable pancreatic Ductal Adenocarcinomas.
    Miyata Y; Yonamine N; Fujinuma I; Tsunenari T; Takihata Y; Hakoda H; Nakazawa A; Iwasaki T; Einama T; Togashi J; Tsujimoto H; Ueno H; Beck Y; Kishi Y
    Ann Surg Oncol; 2023 Dec; 30(13):8621-8630. PubMed ID: 37658273
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prognostic significance of ımmunhistochemical axl expression in pancreas ductal adenocarcinomas.
    Oz O; Argon A; Kebat TA; Ozdemir O; Yakan S
    Indian J Pathol Microbiol; 2023; 66(3):533-539. PubMed ID: 37530334
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Prognostic impact of R1 resection margin in synchronous and simultaneous colorectal liver metastasis resection: a retrospective cohort study.
    Kim NR; Alhothaifi ED; Han DH; Choi JS; Choi GH
    World J Surg Oncol; 2023 Jun; 21(1):169. PubMed ID: 37280633
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The Clinicopathologic Characteristics and Outcomes of Gastroentero-pancreatic Neuroendocrine Tumors - Experience from A Tertiary cancer Center.
    Ali J; Rahat A; Shah MH; Sajjad M; Malik I; Ikram SI; Ul Qamar MF
    Gulf J Oncolog; 2022 Sep; 1(40):7-14. PubMed ID: 36448065
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Recent trends in the incidence and survival of stage I liver cancer: a surveillance, epidemiology, and end results analysis.
    Yu XC; Liu JB; Tang QH; Diao X; Fan QY; Huang ZY; Tang XM; Li S; Cao YF; Ma YS; Fu D
    Ann Med; 2022 Dec; 54(1):2785-2795. PubMed ID: 36370068
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Prognostic Impact of Positive Peritoneal Lavage Cytology on Resectable pancreatic Body and Tail cancer: A Retrospective Study.
    Mashiko T; Ogasawara T; Masuoka Y; Ei S; Takahashi S; Hirabayashi K; Mori M; Koyanagi K; Yamamoto S; Nakagohri T
    World J Surg; 2023 Mar; 47(3):729-739. PubMed ID: 36357802
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Lymph Node Ratio Nomogram-Based Prognostic Model for Resected Distal Cholangiocarcinoma.
    Perez M; Hansen CP; Burdio F; Pellino G; Pisanu A; Salvia R; Di Martino M; Abu Hilal M; Aldrighetti L; Ielpo B;
    J Am Coll Surg; 2022 Nov; 235(5):703-712. PubMed ID: 36102558
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Evolving knowledge in surgical oncology of pancreatic cancer: from theory to clinical practice-a fifteen-year journey at a tertiary referral centre.
    Casadei R; Ricci C; Ingaldi C; Alberici L; De Raffele E; Barcia B; Mosconi C; Diegoli M; Di Marco M; Brandi G; Zagari RM; Pagano N; Eusebi LH; Serra C; Migliori M; Guido A; Santini D; Rosini F; Malvi D; Minni F
    Updates Surg; 2022 Oct; 74(5):1533-1542. PubMed ID: 36008632
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Comparison of the clinical efficacy of a new prognostic stratification for duodenal adenocarcinoma with that of TNM staging: The importance of T status with regard to the prognosis.
    Kato T; Ono Y; Oba A; Sato T; Ito H; Inoue Y; Saiura A; Takahashi Y
    Eur J Surg Oncol; 2023 Jan; 49(1):122-128. PubMed ID: 35999143
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prognostic Factors and Survival in Gastrointestinal Extrapulmonary Small Cell Carcinoma: A Retrospective Cohort Study.
    Ulanja MB; Beutler BD; Antwi-Amoabeng D; Governor SB; Rahman GA; Djankpa FT; Alese OB
    Ann Surg Oncol; 2022 Dec; 29(13):8250-8260. PubMed ID: 35978206
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prognostic value of tumor-infiltrating CD163
    Kinoshita J; Fushida S; Yamaguchi T; Moriyama H; Saito H; Shimada M; Terai S; Okamoto K; Nakamura K; Ninomiya I; Yagi S; Inaki N
    BMC Cancer; 2022 Jun; 22(1):608. PubMed ID: 35658848
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Complications and chemotherapy have little impact on postoperative quality of life after pancreaticoduodenectomy - a cohort study.
    Johansen K; Lindhoff Larsson A; Gasslander T; Lundgren L; Hasselgren K; Sandström P; Borch K; Björnsson B
    HPB (Oxford); 2022 Sep; 24(9):1464-1473. PubMed ID: 35410782
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Association of Adjuvant Chemotherapy With Overall Survival Among Patients With Locally Advanced Gastric cancer After Neoadjuvant Chemotherapy.
    Lin JX; Tang YH; Lin GJ; Ma YB; Desiderio J; Li P; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Zheng CH; Parisi A; Truty MJ; Huang CM
    JAMA Netw Open; 2022 Apr; 5(4):e225557. PubMed ID: 35363268
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Importance of Nodal Metastases Location in Pancreatoduodenectomy for pancreatic Ductal Adenocarcinoma: Results from a Prospective, Lymphadenectomy Protocol.
    Malleo G; Maggino L; Casciani F; Lionetto G; Nobile S; Lazzarin G; Paiella S; Esposito A; Capelli P; Luchini C; Scarpa A; Bassi C; Salvia R
    Ann Surg Oncol; 2022 Jun; 29(6):3477-3488. PubMed ID: 35192154
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Cytoreductive surgery and HIPEC for peritoneal metastasis. Justified hope or desperate illusion? Fifteen years of experience from a Greek Peritoneal Surface Malignancy center.
    Spiliotis J; Kopanakis N; Terra A; Iavazzo C; Prodromidou A; Rogdakis A; Efstathiou E
    J BUON; 2021; 26(4):1669-1678. PubMed ID: 34565035
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Indication of Surgical Hepatectomy for the Patients of Hepatocellular Carcinoma with Inferior Vena Cava Tumor Thrombosis.
    Nishizawa Y; Kuramitsu K; Kido M; Komatsu S; Gon H; Urade T; So S; Ishida J; Shirakawa S; Yamashita H; Tsugawa D; Terai S; Asari S; Yanagimoto H; Toyama H; Ajiki T; Fukumoto T
    Kobe J Med Sci; 2021 Jun; 67(1):E10-E17. PubMed ID: 34344853
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Comparison of Survival and Patterns of Recurrence in Gastric Neuroendocrine Carcinoma, Mixed Adenoneuroendocrine Carcinoma, and Adenocarcinoma.
    Lin J; Zhao Y; Zhou Y; Tian Y; He Q; Lin J; Hao H; Zou B; Jiang L; Zhao G; Lin W; Xu Y; Li Z; Xue F; Li S; Fu W; Li Y; Xu Z; Li Y; Chen J; Zhou X; Zhu Z; Cai L; Li E; Li H; Zheng C; Li P; Huang C; Xie J
    JAMA Netw Open; 2021 Jul; 4(7):e2114180. PubMed ID: 34313744
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 8.